John J. Gullo

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.

J J Lokich, James D. Ahlgren, John J. Gullo et al. · Journal of Clinical Oncology · 1989 · 768 citations

Surgical Oncology, Cancer Management, Surgery +18

Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion

John J. Gullo, Charles L. Litterst, Patrick Maguire et al. · Cancer Chemotherapy and Pharmacology · 1980 · 193 citations

Biochemistry, Twenty Hour Infusion, Medicine +4

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.

Stephen L. Graziano, Rummana Mazid, Nancy Newman et al. · Journal of Clinical Oncology · 1989 · 189 citations

Tumor Biology, Chemotherapy Response, Non-small-cell Lung Cancer +15

Adverse prognostic effect of N2 disease in treated small cell carcinoma of the lung

John A. Meyer, John J. Gullo, Phillip M. Ikins et al. · Journal of Thoracic and Cardiovascular Surgery · 1984 · 68 citations

N2 Disease, Medicine, Pathology +7

Phase II trial of extended indications for resection is small cell carcinoma of the lung.

John A. Meyer, Robert L. Comis, Sandra J. Ginsberg et al. · PubMed · 1982 · 61 citations

Surgical Oncology, Advanced Lung Disease, Patient Selection +18